Global Head And Neck Cancer Therapeutics Market Size & Outlook

The global head and neck cancer therapeutics market size was estimated at USD 2,273.4 million in 2024 and is projected to reach USD 6,254.3 million by 2033, growing at a CAGR of 12% from 2025 to 2033.
Revenue, 2024 (US$M)
$2,273.4
Forecast, 2033 (US$M)
$6,254.3
CAGR, 2025 - 2033
12%
Report Coverage
Worldwide

Global head and neck cancer therapeutics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global head and neck cancer therapeutics market highlights

  • The global head and neck cancer therapeutics market generated a revenue of USD 2,273.4 million in 2024 and is expected to reach USD 6,254.3 million by 2033.
  • The market is expected to grow at a CAGR (2025 - 2033) of 12% by 2033.
  • In terms of segment, immunotherapy accounted for a revenue of USD 1,531.4 million in 2024.
  • Immunotherapy is the most lucrative type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, UAE is expected to register the highest CAGR from 2025 to 2033.

Global data book summary

Market revenue in 2024USD 2,273.4 million
Market revenue in 2033USD 6,254.3 million
Growth rate12% (CAGR from 2025 to 2033)
Largest segmentImmunotherapy
Fastest growing segmentImmunotherapy
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationChemotherapy, Immunotherapy, Targeted Therapy

Other key industry trends

  • In terms of revenue, the North America accounted for 44.8% of the global head and neck cancer therapeutics market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, UAE is the fastest growing regional market and is projected to reach USD 38.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Head And Neck Cancer Therapeutics Market Companies

Name Profile # Employees HQ Website
Clinigen Group View profile 1001-5000 Burton-on-trent, St. Helens, United Kingdom, Europe http://clinigengroup.com
Takeda Pharmaceutical Co Ltd View profile 49095 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 https://www.takeda.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Eli Lilly and Co View profile 43000 Lilly Corporate Center, Indianapolis, IN, United States, 46285 https://www.lilly.com
Bristol-Myers Squibb Co View profile 34100 Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 https://www.bms.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

Global head and neck cancer therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to head and neck cancer therapeutics market will help companies and investors design strategic landscapes.


Immunotherapy was the largest segment with a revenue share of 67.36% in 2024. Horizon Databook has segmented the Global head and neck cancer therapeutics market based on chemotherapy, immunotherapy, targeted therapy covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Head And Neck Cancer Therapeutics Type Outlook (Revenue, USD Million, 2021-2033)
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • Global Head And Neck Cancer Therapeutics Route of Administration Outlook (Revenue, USD Million, 2021-2033)
    • Oral
    • Injectable
  • Global Head And Neck Cancer Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
    • Online Pharmacies
    • Retail & Specialty Pharmacies
    • Hospital Pharmacies

Reasons to subscribe to Global head and neck cancer therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global head and neck cancer therapeutics market databook

  • Our clientele includes a mix of head and neck cancer therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global head and neck cancer therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global head and neck cancer therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global head and neck cancer therapeutics market size, by regions, 2021-2033 (US$M)

Top 10 countries: Head and neck cancer therapeutics market size, 2024 (US$M)

Global head and neck cancer therapeutics market share, by type, 2024 & 2033 (%, US$M)

Head and neck cancer therapeutics market: Opportunity assessment by country

Global head and neck cancer therapeutics market, by region, 2024 (US$M)

Global head and neck cancer therapeutics market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online